Immatics N.V. Completes Share Offering
Ticker: IMTX · Form: 6-K · Filed: Oct 15, 2024 · CIK: 1809196
Sentiment: neutral
Topics: equity-offering, capital-raise, underwriting
TL;DR
Immatics just sold 16.25M shares via Jefferies, BofA, Leerink - raising cash!
AI Summary
On October 15, 2024, Immatics N.V. completed an offering of 16,250,000 ordinary shares. The offering was conducted through an underwriting agreement with Jefferies LLC, Jefferies GmbH, BofA Securities, Inc., and Leerink Partners LLC. The company also granted the underwriters a 30-day option to purchase additional shares.
Why It Matters
This share offering provides Immatics with additional capital, which can be used to fund its ongoing research and development activities in the biotechnology sector.
Risk Assessment
Risk Level: medium — Share offerings can dilute existing shareholders and the success of the company depends on the effective use of the raised capital for its R&D pipeline.
Key Numbers
- 16,250,000 — Ordinary Shares Offered (Represents the volume of the capital raise through the share offering.)
Key Players & Entities
- Immatics N.V. (company) — Company completing the share offering
- Jefferies LLC (company) — Underwriter in the share offering
- Jefferies GmbH (company) — Underwriter in the share offering
- BofA Securities, Inc. (company) — Underwriter in the share offering
- Leerink Partners LLC (company) — Underwriter in the share offering
- 16,250,000 (dollar_amount) — Number of ordinary shares offered
FAQ
What was the total number of ordinary shares offered by Immatics N.V.?
Immatics N.V. offered 16,250,000 ordinary shares.
What is the date of the share offering completion?
The share offering was completed on October 15, 2024.
Who were the underwriters for this share offering?
The underwriters included Jefferies LLC, Jefferies GmbH, BofA Securities, Inc., and Leerink Partners LLC.
Did Immatics N.V. grant any options related to the offering?
Yes, Immatics N.V. granted the underwriters an option, exercisable for 30 days, to purchase additional shares.
What type of shares were offered in the offering?
Immatics N.V. completed an offering of ordinary shares.
Filing Stats: 653 words · 3 min read · ~2 pages · Grade level 9.8 · Accepted 2024-10-15 16:10:19
Key Financial Figures
- $140.3 m — ale of the securities are approximately $140.3 million, after deducting the underwriting
Filing Documents
- dp219304_6k.htm (6-K) — 14KB
- dp219304_ex0101.htm (EX-1.1) — 253KB
- dp219304_ex0501.htm (EX-5.1) — 68KB
- dp219304_ex9901.htm (EX-99.1) — 14KB
- dp219304_ex9902.htm (EX-99.2) — 14KB
- image_001.jpg (GRAPHIC) — 1KB
- image_002.jpg (GRAPHIC) — 2KB
- image_003.jpg (GRAPHIC) — 5KB
- image_004.jpg (GRAPHIC) — 5KB
- image_005.jpg (GRAPHIC) — 5KB
- 0000950103-24-014943.txt ( ) — 390KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMATICS N.V. Date: October 15, 2024 By: /s/ Harpreet Singh Name: Harpreet Singh Title: Chief Executive Officer